Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Gardasil HPV Vaccine Lawsuit Side effects of the Gardasil HPV vaccine have been linked to reports of serious and debilitating autoimmune injuries. Lawyers review cases nationwide.
California Investigating Cluster of Birth Defects in Kettleman City February 2, 2010 Staff Writers Add Your Comments Health investigators have begun looking into a number of birth defects that have occurred in Kettleman City, a small town in Kings County, California. Residents suspect that the Kettleman City birth defects may be caused by hazardous waste from a nearby chemical disposal facility, which has been looking to expand. Governor Arnold Schwarzenegger ordered both the California Department of Public Health and the California Environmental Protection Agency (CAL-EPA) to take aggressive action to investigate the environmental and health issues in Kettleman City on Friday. Out of 20 children born in the town of 1,500 between September 2007 and November 2008, five had facial birth defects. Residents also say there have been a high number of miscarriages as well. The probe was launched after residents protested outside of U.S. EPA headquarters last week. Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… Childhood Diabetes Lawsuits Against Junk Food Industry Lawyers are now pursuing financial compensation for families of children diagnosed with Type II diabetes, fatty liver disease and other chronic illnesses caused by addictive and harmful substances in ultra-processed foods. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Chemical Waste Management, Inc. seeks to expand a nearby hazardous waste disposal facility which is already the largest in the western part of the country. Residents were unsuccessful in convincing the Kings County Board of Supervisors to deny the company permission to expand the facility last year. Chemical Waste Management officials say that they believe their facility meets all state standards and is not playing a role in the recent cluster of birth defects in Kettleman City. Some have suggested that Kettleman City may also be exposed to potential health problems due to diesel emissions or pesticides used on nearby farms. The town is located between San Francisco and Los Angeles on Interstate 5, a major trucking corridor. “There is nothing more important than the health and safety of the public,” Governor Schwarzenegger said. “My administration is committed to the community of Kettleman City and will use our resources to conduct a thorough investigation to provide these hard-working people with answers and the peace of mind they deserve.” CAL-EPA and state health officials will present their initial findings on February 9. Tags: Birth Defect, California, Kettleman City Birth Defect More Lawsuit Stories Suboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage March 11, 2025 Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals March 11, 2025 3M Seeks Dismissal of More Than 100 Bair Hugger Infection Lawsuits March 11, 2025 2 Comments John March 22, 2010 Beware of the State officials who will be prone to favor commerce first. Beware of commercial entities, they will definitely use deceptions to obtain profit. Collateral damage will matter little to them. Sylvia November 17, 2010 I was DX w/ cirrosis of the liver…… Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Suboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (Posted: today) Suboxone lawyers will meet today with a federal judge, to discuss the status of thousands of tooth decay lawsuits brought over the opioid treatment film strips. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITMedical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)Another Influx of Suboxone Tooth Decay Lawsuits Expected in Coming Months (01/20/2025) 75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (Posted: yesterday) The MDL Judge will hear presentations from Depo-Provera lawyers seeking leadership positions during a two day hearing on March 13th and 14th, as a growing number of women continue to file brain tumor lawsuits against the makers of the popular birth control shot. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025)Judge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025) Cartiva Implant Injury Lawsuit Set for Trial in February 2026 (Posted: 4 days ago) A West Virginia woman’s lawsuit over complications with a Cartiva implant has been scheduled to go before a jury in February 2026, involving claims that the big toe implant failed just weeks before the manufacturer issued a Cartiva recall. MORE ABOUT: CARTIVA IMPLANT LAWSUITLawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)Cartiva Implant Failure Symptoms Reported By Big Toe Surgery Patients in Lawsuits, Social Media and FDA Adverse Events (12/26/2024)
Brazilian Blowout Cancer Lawsuit Filed by Missouri Hair Stylists Over Exosure to Toxic Chemicals March 11, 2025
Suboxone Lawyers Report on Status of Lawsuits Over Tooth Decay, Dental Damage (Posted: today) Suboxone lawyers will meet today with a federal judge, to discuss the status of thousands of tooth decay lawsuits brought over the opioid treatment film strips. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITMedical Records of Suboxone Tooth Decay Must Be Produced Under MDL Court Order (02/20/2025)Lawyers in Suboxone Dental Lawsuits Fail To Reach Agreement on Bellwether Selection Process (02/06/2025)Another Influx of Suboxone Tooth Decay Lawsuits Expected in Coming Months (01/20/2025)
75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (Posted: yesterday) The MDL Judge will hear presentations from Depo-Provera lawyers seeking leadership positions during a two day hearing on March 13th and 14th, as a growing number of women continue to file brain tumor lawsuits against the makers of the popular birth control shot. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Side Effects May Increase Risk of Rare, Severe Blood Clots, Case Report Warns (03/05/2025)Depo-Provera Injury Lawyers To Apply for Leadership Positions in MDL (03/03/2025)Judge Selects Five Depo-Provera Brain Tumor Lawsuits for “Pilot” Trials Weeks After MDL Established (02/25/2025)
Cartiva Implant Injury Lawsuit Set for Trial in February 2026 (Posted: 4 days ago) A West Virginia woman’s lawsuit over complications with a Cartiva implant has been scheduled to go before a jury in February 2026, involving claims that the big toe implant failed just weeks before the manufacturer issued a Cartiva recall. MORE ABOUT: CARTIVA IMPLANT LAWSUITLawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)Cartiva Implant Failure Symptoms Reported By Big Toe Surgery Patients in Lawsuits, Social Media and FDA Adverse Events (12/26/2024)